WeTrials shared a post on LinkedIn:
“Better, Safer Treatment for Childhood Cancer
Childhood cancer care is evolving. With genomic sequencing now guiding treatment decisions at many centers, clinicians can better understand what’s driving a child’s cancer at the molecular level.
This allows for more targeted approaches and a focus on reducing long-term health complications — helping children not only overcome cancer, but grow into healthier adults.”
More posts about WeTrials.